Funded Health Care Startups in Dublin
Across these 19 funded Health Care startups listed for Dublin, ProVerum Medical’s $80M Series B (2025-08-25) stands out as the only disclosed round above $…
Across these 19 funded Health Care startups listed for Dublin, ProVerum Medical’s $80M Series B (2025-08-25) stands out as the only disclosed round above $50M, with the next-largest disclosed amount at $33M (DeepVerge, 2022-03-19). Most disclosed rounds cluster in modest bands: several are in the $3M–$18M range (e.g., SISU Aesthetic Clinic $15M on 2025-01-08; Spectrum Life $18M on 2024-05-27), while smaller disclosed entries like Ulysses Neuroscience ($530K on 2024-04-17) and MEG Support Tools ($500K on 2020-09-23) form the lower edge.
The funding dates span from 2020-09-23 (MEG Support Tools) to 2025-08-25 (ProVerum Medical). Eighteen of the 19 companies are Dublin-based (with one entry also explicitly labeled “Dublin, Dublin”), and the list is stage-mixed but disclosure-heavy: 9 of 19 rows are “Series Unknown” or blank, and 2 of 19 are “undisclosed.” There is also a temporal lift in the most recent window, with multiple rounds closing in 2024–2025 (e.g., Novus Diagnostics $5M on 2025-01-15; LaNua Medical $6M on 2024-12-12; Spectrum Life $18M on 2024-05-27).
Most recent rounds
19 shownRelated listings
Frequently asked
What’s the largest disclosed round here, and how does it compare with the rest of the Dublin Health Care list?
ProVerum Medical’s $80M disclosed Series B (2025-08-25) is the only disclosed round above $50M. The next-highest disclosed amount is $33M (DeepVerge, 2022-03-19), so that single round is far above the rest of the disclosed figures.
Do the rounds cluster in a narrow timeframe near the top of the date range?
Yes. Several entries fall within 2024–2025, including SISU Aesthetic Clinic $15M (2025-01-08), Novus Diagnostics $5M (2025-01-15), CroíValve $3M (2025-07-01), LaNua Medical $6M (2024-12-12), and Spectrum Life $18M (2024-05-27), which compresses many of the newer rounds into the last ~20 months of the listing.
How much of this list is non-disclosed or unknown stage, and what does that imply for filtering?
9 of 19 rows are labeled “Series Unknown” or have a blank round type (e.g., CroíValve 2025-07-01, Altach Biomedical 2024-05-22, HealthBeacon 2020-11-24). In addition, 2 of 19 rounds show “undisclosed” amounts (Ostoform 2022-10-21; Latch Medical 2022-08-11), so analysts may need to rely more on dates and deal sizes where available.
Which disclosed amounts are at the extremes, and are the outliers concentrated at the high end or the low end?
The high-end outlier is ProVerum Medical’s $80M (2025-08-25). On the low end, the smallest disclosed amounts are $500K for MEG Support Tools (2020-09-23) and $530K for Ulysses Neuroscience (2024-04-17), both well below mid-tier disclosed rounds like Selio Medical $3M (2022-07-14) and Fettle $540K (2023-08-17).
Is Dublin geography consistent across entries, or are there conflicting city labels that would affect outreach lists?
Geographically, the city label is overwhelmingly consistent as Dublin, Ireland across the rows. The main disambiguation is ProVerum Medical, which is explicitly listed as “Dublin, Dublin, Ireland” while others are shown as “Dublin, Ireland” (e.g., Spectrum Life $18M on 2024-05-27; Amryt Pharma $125M on 2022-02-22).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.